Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvs crawled time : 12:30 save search
Immutep Announces Second Japanese Patent Grant for LAG-3 Antagonist Antibody LAG525
Published: 2022-03-18 (Crawled : 12:30) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.11%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.17%
H: 1.2%
C: 1.01%
IMMP | News | $2.25 2.27% 2.22% 90K
|
Health Technology
|
| O: 3.31%
H: 11.74%
C: 10.32%
lag525 patent antibody grant granted
BeiGene Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-25 (Crawled : 12:30) - biospace.com/
ZYME | $8.85 2.08% 2.03% 550K
|
Health Technology
|
| O: 2.5%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: 0.0%
financial results report results
Global Nuclear Medicine Market Research Report 2021
Published: 2021-12-31 (Crawled : 12:30) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.14%
H: 0.33%
C: -0.13%
CAH | $108.19 2.07% 0.0% 1.5M
|
Distribution Services
|
| O: -0.75%
H: 0.44%
C: -0.56%
research market
Global Outlook for the Nanomedicine Market 2021-2026: Extensive R&D and Technological Advancements Driving Market Growth
Published: 2021-12-30 (Crawled : 12:30) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.26%
H: 0.4%
C: -0.49%
GE | $148.06 -3.19% 0.0% 9.5M
|
Electronic Technology
|
| O: -0.14%
H: 1.39%
C: 0.04%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.16%
H: 0.24%
C: -0.29%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.08%
H: 0.26%
C: -0.2%
growth
Novartis to acquire Gyroscope Therapeutics, adding a one-time gene therapy that could transform care for geographic atrophy, a leading cause of blindness
Published: 2021-12-22 (Crawled : 12:30) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.55%
H: 0.99%
C: 0.92%
novartis gene therapy therapeutics therapy
BeiGene Expands Collaboration with Novartis to Develop and Commercialize BeiGene’s TIGIT Inhibitor and Market Five Novartis Oncology Medicines in China Broad Markets
Published: 2021-12-20 (Crawled : 12:30) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.03%
H: 0.24%
C: -0.15%
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 8.83%
H: 0.11%
C: -4.16%
novartis china collaboration
Generic Injectable Market to Top US$ 85 Bn by 2031, Growing Burden of Lifestyle Diseases to Accelerate the Sales: FMI
Published: 2021-11-24 (Crawled : 12:30) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.33%
H: 0.0%
C: 0.0%
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.02%
H: 1.33%
C: 1.33%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.41%
H: 0.2%
C: 0.11%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.19%
H: 0.83%
C: -0.29%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
disease sales growing
Value-Based Pricing Paving Affordability & Enhancing Access to Generic Oncology Drugs to Reduce Cancer burden
Published: 2021-11-24 (Crawled : 12:30) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.8%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.41%
H: 0.2%
C: 0.11%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.85%
H: 0.07%
C: -0.17%
ford cancer drug
Novartis' KISQALI (ribociclib) product monograph in Canada now includes MONALEESA-3 data demonstrating statistically significant improvement in overall survival in postmenopausal women with HR+/HER2- advanced breast cancer
Published: 2021-03-18 (Crawled : 12:30) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.56%
H: 0.83%
C: 0.02%
women cancer breast cancer her2+ her2- her2
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.